SCHEMBL3227733

SCHEMBL3227733

COc1ccc(COCc2nc(OCc3ccccc3)c(C#N)cc2C(=O)F)cc1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.43
HPGD P15428 4/20 0.43
ALDH1A1 P00352 3/20 0.43
GAA P10253 2/20 0.43
GLA P06280 1/20 0.43
MAPT P10636 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
NPSR1 Q6W5P4 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
XDH P47989 3/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
CNR1 P21554 1/20 0.40
MTNR1A P48039 1/20 0.39
MTNR1B P49286 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3231923 0.93 KDM4E (0.45) KDM4EHPGDALDH1A1GAAGLA
SCHEMBL3226903 0.89 KDM4E (0.54) KDM4EHPGDALDH1A1GAAGLA
SCHEMBL3232013 0.89 SMN1; SMN2 (0.42) KDM4EHPGDALDH1A1GAAGLA
SCHEMBL3941050 0.78 SMN1; SMN2 (0.39) KDM4EHPGDALDH1A1GAAGLA
SCHEMBL9449258 0.74 CNR1 (0.47) L3MBTL1XDHCNR1
SCHEMBL3330291 0.73 KDM4E (0.48) KDM4EHPGDALDH1A1GAAMAPT
SCHEMBL9846091 0.71 ALDH1A1 (0.53) KDM4EHPGDALDH1A1GAATDP1
SCHEMBL9585493 0.69 HTT (0.65) KDM4EHPGDALDH1A1GAAMAPT
SCHEMBL5041808 0.69 SMPD1 (0.57) HPGDALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL9846090 0.67 KDM4E (0.69) KDM4EHPGDALDH1A1GAATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010005384-A1 KETONE PYRIDINE ANALOGUES AND THEIR USE IN THE TREATMENT OF CARDIOVASCULAR DISORDERS ASTRAZENECA AB (SE) 2010-01-14 WO disclosed